136 related articles for article (PubMed ID: 2947645)
21. Iloprost reduces procoagulant activity in the extracorporeal circuit.
Korn RL; Fisher CA; Stenach N; Jeevanandam V; Addonizio VP
J Surg Res; 1993 Oct; 55(4):433-40. PubMed ID: 7692141
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation.
Kappelmayer J; Bernabei A; Gikakis N; Edmunds LH; Colman RW
J Lab Clin Med; 1993 Jan; 121(1):118-26. PubMed ID: 8426073
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil degranulation and complement activation during fetal cardiac bypass.
Parry AJ; Petrossian E; McElhinney DB; Reddy VM; Hanley FL
Ann Thorac Surg; 2000 Aug; 70(2):582-9. PubMed ID: 10969684
[TBL] [Abstract][Full Text] [Related]
24. Complement, leukocytes, and leukocyte elastase in full-term neonates undergoing cardiac operation.
Seghaye MC; Duchateau J; Grabitz RG; Nitsch G; Marcus C; Messmer BJ; von Bernuth G
J Thorac Cardiovasc Surg; 1994 Jul; 108(1):29-36. PubMed ID: 8028376
[TBL] [Abstract][Full Text] [Related]
25. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation.
Fromes Y; Gaillard D; Ponzio O; Chauffert M; Gerhardt MF; Deleuze P; Bical OM
Eur J Cardiothorac Surg; 2002 Oct; 22(4):527-33. PubMed ID: 12297167
[TBL] [Abstract][Full Text] [Related]
26. Quantitation of platelet preservation with prostanoids during simulated bypass.
Kappa JR; Musial J; Fisher CA; Addonizio VP
J Surg Res; 1987 Jan; 42(1):10-8. PubMed ID: 2433503
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass.
Finn A; Naik S; Klein N; Levinsky RJ; Strobel S; Elliott M
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):234-41. PubMed ID: 8429650
[TBL] [Abstract][Full Text] [Related]
28. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans.
Faymonville ME; Pincemail J; Duchateau J; Paulus JM; Adam A; Deby-Dupont G; Deby C; Albert A; Larbuisson R; Limet R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):309-17. PubMed ID: 1650868
[TBL] [Abstract][Full Text] [Related]
29. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase type 4 inhibition of activated polymorphonuclear leukocytes in a simulated extracorporeal circulation model.
Sato Y; Hiramatsu Y; Homma S; Sato S; Onizuka M; Sakakibara Y
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):172-7. PubMed ID: 12539001
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators.
Gillinov AM; Bator JM; Zehr KJ; Redmond JM; Burch RM; Ko C; Winkelstein JA; Stuart RS; Baumgartner WA; Cameron DE
Ann Thorac Surg; 1993 Oct; 56(4):847-53. PubMed ID: 8105757
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
Kanemitsu S; Nishikawa M; Onoda K; Shimono T; Shimpo H; Yazaki A; Tanaka K; Shiku H; Yada I
J Thorac Cardiovasc Surg; 2003 Aug; 126(2):428-35. PubMed ID: 12928640
[TBL] [Abstract][Full Text] [Related]
33. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.
Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP
J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305
[TBL] [Abstract][Full Text] [Related]
34. Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation.
Gikakis N; Khan MM; Hiramatsu Y; Gorman JH; Hack CE; Sun L; Rao AK; Niewiarowski S; Colman RW; Edmunds LH
Circulation; 1996 Nov; 94(9 Suppl):II341-6. PubMed ID: 8901772
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of new surface coatings for extracorporeal circulation.
Baksaas ST; Videm V; Fosse E; Karlsen H; Pedersen T; Mollnes TE; Hagve TA; Svennevig JL
Perfusion; 1999 Jan; 14(1):11-9. PubMed ID: 10074642
[TBL] [Abstract][Full Text] [Related]
36. Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst.
Huizinga TW; Dolman KM; van der Linden NJ; Kleijer M; Nuijens JH; von dem Borne AE; Roos D
J Immunol; 1990 Feb; 144(4):1432-7. PubMed ID: 2137491
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil activation in paediatric extracorporeal circuits: effect of circulation and temperature variation.
el Habbal MH; Carter H; Smith LJ; Elliott MJ; Strobel S
Cardiovasc Res; 1995 Jan; 29(1):102-7. PubMed ID: 7534645
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits.
Fung M; Loubser PG; Undar A; Mueller M; Sun C; Sun WN; Vaughn WK; Fraser CD
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):113-22. PubMed ID: 11436043
[TBL] [Abstract][Full Text] [Related]
39. Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation.
Wachtfogel YT; Abrams W; Kucich U; Weinbaum G; Schapira M; Colman RW
J Clin Invest; 1988 May; 81(5):1310-6. PubMed ID: 2966812
[TBL] [Abstract][Full Text] [Related]
40. Loss of platelet alpha 2-adrenergic receptors during simulated extracorporeal circulation: prevention with prostaglandin E1.
Wachtogel YT; Musial J; Jenkin B; Niewiarowski S; Edmunds LH; Colman RW
J Lab Clin Med; 1985 May; 105(5):601-7. PubMed ID: 4039346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
